Mel Sorensen Galera Therapeutics, Inc. (GRTX) insider trading activity
Mel Sorensen is President and CEO of Galera Therapeutics, Inc.. Currently has a direct ownership of 265,029 shares of GRTX, which is worth approximately $13,251. The most recent transaction as insider was on Aug 16, 2024, when has been sold 67,015 shares (Common Stock) at a price of $0.07 per share, resulting in proceeds of $4,691. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
265K
20.18%
3M change
20.18%
12M change
Total Value Held
$13,251
Mel Sorensen Transaction History
MS
Mel Sorensen
President and CEO
Malvern, PA